SS 32 - Lung 4: Clinical Trials of SBRT and Hypofractionation for NSCLC

Moderator(s)

• 

  Annemarie Shepherd, MD

  University of Washington
  Seattle, Washington, United States
• 

  Andrew Baschnagel, MD

  University of Wisconsin Hospitals and Clinics
  Madison, WI

Presentations:

• 12:45 PM – 12:55 PM ET

  Measuring the Integration of Stereotactic Ablative Radiotherapy plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes
  

  Presenter: Vivian Tan, MD – London Health Sciences Centre
• 12:55 PM – 1:05 PM ET

  A Phase II Randomized Trial of Radical Resection vs. Stereotactic Body Radiation Therapy (SBRT) in Patients with Operable Stage I Non-Small Cell Lung Cancer (NSCLC): Final Report Of RTOG-F3502
  

  Presenter: Feng-Ming Kong, MD, PhD, FASTRO, FACR – University of Hong Kong
• 1:05 PM – 1:15 PM ET

  A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
  

  Presenter: Mark Farrugia, MD, PhD – Roswell Park Cancer Institute
• 1:15 PM – 1:25 PM ET

  Dosimetric Outcomes of SBRT to Ultracentral Lung Tumors: Lessons from the SUNSET Trial
  

  Presenter: Rohan Salunkhe, MD, MBBS – Princess Margaret Cancer Center, University Health Network
• 1:25 PM – 1:35 PM ET

  Accelerated Hypofractionated Chemoradiation Followed by Stereotactic Ablative Radiotherapy Boost for Locally Advanced, Unresectable Non-Small Cell Lung Cancer: Final Results from a Nonrandomized Contr
  

  Presenter: Percy Lee, MD, FASTRO – City of Hope National Medical Center
• 1:35 PM – 1:45 PM ET

  A Phase I Study of Cyclical Hypofractionated Palliative Radiation (Quad Shot) for Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial
  

  Presenter: Helen Zhang, MD – Memorial Sloan Kettering Cancer Center
• 1:45 PM – 1:55 PM ET

  Discussant
  

  Discussant: Clifford Robinson, MD, FASTRO – Washington University School of Medicine in St. Louis